Advertisement
Canada markets open in 1 hour 52 minutes
  • S&P/TSX

    22,259.47
    +312.06 (+1.42%)
     
  • S&P 500

    5,180.74
    +52.95 (+1.03%)
     
  • DOW

    38,852.27
    +176.59 (+0.46%)
     
  • CAD/USD

    0.7311
    -0.0010 (-0.14%)
     
  • CRUDE OIL

    78.21
    -0.27 (-0.34%)
     
  • Bitcoin CAD

    87,598.57
    -282.88 (-0.32%)
     
  • CMC Crypto 200

    1,328.82
    -36.31 (-2.66%)
     
  • GOLD FUTURES

    2,324.40
    -6.80 (-0.29%)
     
  • RUSSELL 2000

    2,060.67
    +24.95 (+1.23%)
     
  • 10-Yr Bond

    4.4890
    -0.0110 (-0.24%)
     
  • NASDAQ futures

    18,162.25
    -33.25 (-0.18%)
     
  • VOLATILITY

    13.57
    +0.08 (+0.59%)
     
  • FTSE

    8,299.01
    +85.52 (+1.04%)
     
  • NIKKEI 225

    38,835.10
    +599.03 (+1.57%)
     
  • CAD/EUR

    0.6787
    -0.0005 (-0.07%)
     

Does Neurocrine, The No. 1 Biotech Stock, Have The Next Ketamine On Its Hands?

Does Neurocrine, The No. 1 Biotech Stock, Have The Next Ketamine On Its Hands?

Top-notch biotech stock Neurocrine surged Tuesday after analysts suggested the company's depression treatment could rival ketamine.